Claims
- 1. A compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof: ##STR177## wherein: A: hydrogen atom or a phenyl group;
- n: an integer of 3 to 5;
- R.sub.1 : hydrogen atom or a lower alkyl group;
- X.sub.1 : a group shown by --CO--NH--
- B: a group represented by: ##STR178## wherein: R.sub.2 : a carboxy group, a carboxy lower alkyl group, or a group represented by the formula ##STR179## wherein R.sub.4 and R.sub.5, which may be the same or different, is a hydrogen atom, a carboxy-lower alkyl group, a lower alkanoyl group, a carboxy-lower alkanoyl group, an oxalyl group, a lower alkoxy oxalyl group or a mono-lower alkylaminocarbonyl group; and
- X.sub.2 : a group represented by --O--Y.sub.4 --; Y.sub.4 : an alkylene group having 1 to 6 carbon atoms.
- 2. A compound as claimed in claim 1, wherein A represents a phenyl group, n is an integer of 4 or 5, R.sub.1 is a hydrogen atom, X.sub.1 is a group shown by --CO--NH--, B is: ##STR180## wherein R.sub.2 is a carboxy-lower alkyl group or a oxalyl amino group, X.sub.2 is --O--CH.sub.2.
- 3. A compound as claimed in claim 1, which is 4-amino-2-[p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 4. A compound as claimed in claim 1, which is o-[p-(4-phenylbutoxy)benzyloxy]phenoxyacetic acid.
- 5. A compound as claimed in claim 1, which is o-[3-methoxy-4-(4-phenylbutoxy)styryl]phenoxyacetic acid.
- 6. A compound as claimed in claim 1, which is o-[o-(4-phenylbutoxy)styryl]phenoxyacetic acid.
- 7. A compound as claimed in claim 1, which is 4-acetamido-2-[p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 8. A compound as claimed in claim 1, which is 4-oxalamido-2-[p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 9. A compound as claimed in claim 1, which is 4-(2-carboxyacetamido)-2-[p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 10. A compound as claimed in claim 1, which is 4-formyl-2-[p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 11. A compound as claimed in claim 1, which is 5-carboxy-2-]p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 12. A compound as claimed in claim 1, which is 5-(2-carboxy)ethyl-2-[p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 13. A compound as claimed in claim 1, which is 4-carboxymethylamino-2-[p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 14. A compound as claimed in claim 1, which is 4-(3-ethylureido)-2-[p-(4-phenylbutoxy)benzamido]phenoxyacetic acid.
- 15. A compound as claimed in claim 1, which is [2-]p-(4-phenylbutoxy)benzamido]-1,4-phenylenedioxy]diacetic acid.
- 16. A pharmaceutical composition useful for inhibiting the production and release of SRS-A comprised of a pharmaceutically acceptable amount of the compound of claim 1 and a pharmaceutically acceptable carrier.
- 17. A method for inhibiting the production and release of SRS-A in a subject, which comprises administering to said subject an effective amount for inhibiting the production and release of SRS-A of the pharmaceutical composition of claim 16.
Priority Claims (2)
Number |
Date |
Country |
Kind |
60-70566 |
Apr 1985 |
JPX |
|
60-297096 |
Dec 1985 |
JPX |
|
Parent Case Info
This is a division of application Ser. No. 899,218, filed Aug. 15, 1986 now U.S. Pat. No. 4,994,479.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4026896 |
Harita et al. |
May 1977 |
|
4322439 |
Klumm et al. |
May 1982 |
|
Non-Patent Literature Citations (1)
Entry |
Drain et al., J. Pharm. Pharmol, 22 (1970) pp. 684-693. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
899218 |
Aug 1986 |
|